Live
- Nifty back below 200EMA/ 200DMAs
- US Navy shoots down own jets over Red Sea
- Nara Devansh sets world record in chess
- Team India cross their fingers
- 3 energy efficient projects to reduce power bills in AP
- Governor Jishnu Dev Varma to Attend ABVP 43rd State Conference in Siddipet Today
- Transgenders to Begin Traffic Assistant Duties in Hyderabad from Tomorrow
- Police Security Tightened at Allu Arjun’s Residence After OU JAC Vandalism
- ED Likely to Issue Notices to BRS Working President KTR Today
- CM Chandrababu Naidu to Attend Christmas Celebrations in Amaravati Today
Dr Reddy's launches Treprostinil injection in US
Representational image
Highlights
City-based pharmaceutical company Dr Reddy’s Laboratories Limited on Friday announced the launch of Treprostinil Injection in the U S market.
Hyderabad: City-based pharmaceutical company Dr Reddy's Laboratories Limited on Friday announced the launch of Treprostinil Injection in the U S market.
A therapeutic equivalent generic version of Remodulin, Treprostinil injection is approved by the U S Food and Drug Administration (USFDA).
Dr Reddy's new launch is supplied in 20 mg/20 ml, 50 mg/20 ml, 100 mg/20 ml or 200mg/20 ml vials. Treprostinil injection is a prostacyclin mimetic indicated for patients who require transition from epoprostenol, to reduce the rate of clinical deterioration, the drug maker said.
Next Story
ADVERTISEMENT
